packageOfatumumab

ofatumumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ofatumumab is a monoclonal antibody used to treat B-cell blood cancers such as chronic lymphocytic leukemia and lymphoma, and is also used for relapsing-remitting multiple sclerosis. It is authorised in the European Union, where one product remains on the market while another has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q410656 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ofatumumab
ATC codes:L01FA02, L01XC10, L04AA52, L04AG12
DrugBank:DB06650
Wikidata:Q410656
molar mass:146100 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown